KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Unbilled Receivables
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Unbilled Receivables of $689.93 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-03.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2018-08-03
- KIORA PHARMACEUTICALS, INC. increase (decrease) in unbilled receivables for the quarter ending 2018-06-30 was -$116.28K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in unbilled receivables for the quarter ending 2018-03-31 was $806.21K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in unbilled receivables for the quarter ending 2017-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in unbilled receivables for the quarter ending 2017-03-31 was $0.00.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month |
|---|---|---|
| 2018-06-30 | -$116.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $689.93K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $806.21K 10-Q · filed 2018-05-11 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |